Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 46, 2014 - Issue 1: Psychedelic Resurgence—Research and Therapeutic Uses, Past and Present
Submit an article Journal homepage
11,871
Views
87
CrossRef citations to date
0
Altmetric
Original Articles

PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program

George R. GreerPrivate practice, Santa Fe, NMCorrespondence[email protected]
, M.D.,
Charles S. GrobProfessor, Department of Psychiatry and Biobehavioral Sciences and Department of Pediatrics, and Director, Division of Child and Adolescent Psychiatry, Harbor-UCLA Medical Center, Torrance, CA
, M.D. &
Adam L. HalberstadtAssistant Research Scientist, Department of Psychiatry, University of California San Diego, La Jolla, CA
, Ph.D.
Pages 73-77 | Published online: 11 Mar 2014

REFERENCES

  • Allsop, D.J.; Norberg, M.M.; Copeland, J.; Fu, S. & Budney, A.J. 2011. The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress. Drug and Alcohol Dependence 119 (1–2): 123–9.
  • Blake, D.D.; Weathers, F.W.; Nagy, L.M.; Kaloupek, D.G.; Gusman, F.D.; Charney, D.S. & Keane, T.M. The development of a clinician-administered PTSD scale. Journal of Traumatic Stress 8: 75–90.
  • Bonn-Miller, M.O.; Vujanovic, A.A. & Drescher, K.D. 2011. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder. Psychology of Addictive Behaviors 25 (3): 485–91.
  • Chhatwal, J.P.; Davis, M.; Maguschak, K.A. & Ressler, K.J. 2005. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 30: 516–24.
  • Cornelius, J.R.; Kirisci, L.; Reynolds, M.; Clark, D.B.; Hayes, J. & Tarter, R. 2010. PTSD contributes to teen and young adult cannabis use disorders. Addict Behav 35 (2): 91–4.
  • Cougle, J.R.; Bonn-Miller, M.O.; Vujanovic, A.A.; Zvolensky, M.J. & Hawkins, K.A. 2011. Posttraumatic stress disorder and cannabis use in a nationally representative sample. Psychology of Addictive Behaviors 25 (3): 554–8.
  • de Bitencourt, R.M.; Pamplona, F.A. & Takahashi R.N. 2013. A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers. Neuropharmacology 64: 389–95.
  • Fraser, G.A. 2009. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neuroscience & Therapeutics 15 (1): 84–8.
  • Mashiah, M. 2012. Personal communication, October 2. Abstract available from first author.
  • New Mexico Department of Health, Medical Cannabis Program. 2011. Medical Cannabis Program Update for the Medical Advisory Board Meeting 10/19/11. Available at: http://www.health.state.nm.us/idb/medicalcannabis/Update%20for%20Medical%20Advisory%20Board%20Meeting%2010-19-11%20(2).pdf (accessed March 30, 2013).
  • New Mexico Department of Health, Medical Cannabis Program. 2012. Enrollment/Re-enrollment Medical Certification Form. Available at: http://nmhealth.org/mcp/documents/NMDOH-MCP-Form-PatientPacket.pdf (accessed March 30, 2013).
  • Pamplona, F.A.; Bitencourt, R.M. & Takahashi, R.N. 2008. Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats. Neurobiology of Learning and Memory 90: 290–3.
  • Pamplona, F.A.; Prediger, R.D.; Pandolfo, P. & Takahashi, R.N. 2006. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology 188: 641–9.
  • Passie, T.; Emrich, H.M.; Karst, M.; Brandt, S.D. & Halpern, J.H. 2012. Mitigation of post-traumatic stress symptoms by cannabis resin: A review of the clinical and neurobiological evidence. Drug Testing and Analysis 4 (7–8): 649–59.
  • Schier, A.R.; Ribeiro, N.P.; Silva, A.C.; Hallak, J.E.; Crippa, J.A.; Nardi, A.E. & Zuardi, A.W. 2012. Cannabidiol, a cannabis sativa constituent, as an anxiolytic drug. The Revista Brasileira de Psiquiatria 34 (suppl. 1): 104–10.
  • Weathers, F.W.; Keane, T.M. & Davidson, J.R.T. 2001. Clinician-administered PTSD scale: A review of the first ten years of research. Depression and Anxiety 13: 132–56.
  • Weathers, F.W.; Ruscio, A.M. & Keane, T.M. 1999. Psychometric properties of nine scoring rules for the clinician-administered posttraumatic stress disorder scale. Psychological Assessment 11 (2): 124–33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.